Interleukin-33/Suppression of Tumorigenicity 2 (IL-33/ST2) Axis in Idiopathic Inflammatory Myopathies and Its Association With Laboratory and Clinical Parameters: A Pilot Study
Rheumatology International - Germany
doi 10.1007/s00296-020-04554-z
Full Text
Open PDFAbstract
Available in full text
Date
March 28, 2020
Authors
Publisher
Springer Science and Business Media LLC